Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Am J Obstet Gynecol. 2012 Mar 30;207(2):107.e1–107.e8. doi: 10.1016/j.ajog.2012.03.030

Table 2.

Anal Cytology and HPV Results for Subjects Diagnosed with Anal Intraepithelial Neoplasia (AIN) 2–3

VISIT 1 VISIT 2 VISIT 3
# Anal Cytology Result Anal HPV HRA Result Days to HRA Result Anal Cytology Result Anal HPV HRA Result Days to HRA Result Anal Cytology Result Anal HPV HRA Result Days to HRA Result
1 LSIL AIN2 90
2 LSIL + AIN3 41
3 LSIL + AIN3 125
4 NILM N/A N/A NILM + AIN2 363
5 ASCUS + AIN1 52 ASCUS + AIN2 283
6 ASCUS + Refused N/A LSIL + AIN2 615
7 LSIL AIN1 30 LSIL AIN2 219
8 LSIL AIN1 30 ASCUS + AIN2 240
9 ASCUS + Refused N/A ASCUS + AIN3 346
10 NILM N/A N/A LSIL AIN3 265
11 ASCUS AIN1 125 NILM N/A N/A ASCUS AIN3 895
12 NILM + Not Referred* N/A ASCUS + NILM 419 LSIL + AIN3 1154

Note: HPV, human papillomavirus; HRA, high resolution anoscopy; NILM, no intraepithelial lesion or malignancy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; AIN, anal intraepithelial neoplasia; N/A, not applicable.

Days from baseline cytology result to HRA.

*

Visit 1 occurred prior to decision to refer subjects with isolated HPV+ for HRA.